ZA200907826B - Neramexane for the treatment of nystagmus - Google Patents

Neramexane for the treatment of nystagmus

Info

Publication number
ZA200907826B
ZA200907826B ZA200907826A ZA200907826A ZA200907826B ZA 200907826 B ZA200907826 B ZA 200907826B ZA 200907826 A ZA200907826 A ZA 200907826A ZA 200907826 A ZA200907826 A ZA 200907826A ZA 200907826 B ZA200907826 B ZA 200907826B
Authority
ZA
South Africa
Prior art keywords
neramexane
nystagmus
treatment
Prior art date
Application number
ZA200907826A
Inventor
Angelika Hanschmann
Albrecht Staeffler
Michael Althaus
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of ZA200907826B publication Critical patent/ZA200907826B/en

Links

ZA200907826A 2007-06-08 2009-11-06 Neramexane for the treatment of nystagmus ZA200907826B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07252336 2007-06-08

Publications (1)

Publication Number Publication Date
ZA200907826B true ZA200907826B (en) 2010-07-28

Family

ID=38565535

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907826A ZA200907826B (en) 2007-06-08 2009-11-06 Neramexane for the treatment of nystagmus

Country Status (1)

Country Link
ZA (1) ZA200907826B (en)

Similar Documents

Publication Publication Date Title
IL259475A (en) Combination therapy for the treatment of diabetes
EP2303184A4 (en) Combination treatment of glaucoma
ZA200906210B (en) 3-Imidazolyl-Indoles for the treatment of proliferative diseases
ZA200902374B (en) Compositions useful for the treatment of diabetes
GB0823480D0 (en) Devices for the treatment of fluids
ZA201006827B (en) Carboxamide-heteroaryl derivatives for the treatment of diabetes
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
GB0909297D0 (en) Composition for the treatment of skin conditions
IL210290A0 (en) Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL211189A0 (en) Compounds for the treatment of peripheral neuropathies
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
EP2358200A4 (en) Substituted bicyclic amines for the treatment of diabetes
ZA201101821B (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin deases
IL202506A0 (en) Neramexane for the treatment of nystagmus
PL2323625T3 (en) New composition for the treatment of ecchymotic pigmentations
GB0723100D0 (en) Treatment of HFnEF
ZA201100468B (en) The treatment of helminthic infections
HK1139050A1 (en) Medicament for the treatment of pneumonia
ZA200907826B (en) Neramexane for the treatment of nystagmus
GB0814043D0 (en) The treatment of skin disorders
GB0602857D0 (en) The treatment of sialorrhoea
GB0809319D0 (en) The treatment of puritus
GB0819518D0 (en) Compounds for the treatment of flaviviral infections